Fusion Pharmaceuticals Inc.
FUSN · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $28,259 | $61,925 | $26,787 | $32,022 |
| Short-Term Investments | $182,735 | $172,153 | $164,561 | $166,074 |
| Receivables | $4,680 | $4,215 | $2,367 | $2,402 |
| Inventory | $0 | $0 | $8,229 | $5,667 |
| Other Curr. Assets | $5,243 | $5,102 | $1,321 | $1,695 |
| Total Curr. Assets | $220,917 | $243,395 | $203,265 | $207,860 |
| Property Plant & Equip (Net) | $24,445 | $23,896 | $24,981 | $23,341 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $73,434 | $14,584 | $15,931 | $28,423 |
| Tax Assets | $4,366 | $3,961 | $6,878 | $5,996 |
| Other NC Assets | $652 | $849 | $2,322 | $2,666 |
| Total NC Assets | $102,897 | $42,441 | $50,112 | $60,426 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $323,814 | $285,836 | $253,377 | $268,286 |
| Liabilities | – | – | – | – |
| Payables | $2,503 | $1,860 | $1,057 | $2,061 |
| Short-Term Debt | $4,288 | $4,163 | $6,166 | $5,357 |
| Tax Payable | $301 | $301 | $299 | $299 |
| Deferred Revenue | $333 | $333 | $727 | $769 |
| Other Curr. Liab. | $13,331 | $9,563 | $9,229 | $8,608 |
| Total Curr. Liab. | $20,756 | $16,220 | $17,478 | $17,094 |
| LT Debt | $49,686 | $34,775 | $46,462 | $45,265 |
| Deferred Rev, NC | $667 | $667 | $667 | $2,667 |
| Deferred Tax Liab, NC | $10,573 | $11,393 | $0 | $0 |
| Other NC Liab. | $301 | $301 | $299 | $299 |
| Total NC Liab. | $61,227 | $47,136 | $47,428 | $48,231 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $81,983 | $63,356 | $64,906 | $65,325 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$410,429 | -$376,759 | -$348,580 | -$331,328 |
| AOCI | -$582 | $237 | -$841 | -$252 |
| Other Equity | $652,842 | $599,002 | $537,892 | $534,541 |
| Total Equity | $241,831 | $222,480 | $188,471 | $202,961 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $323,814 | $285,836 | $253,377 | $268,286 |
| Net Debt | $25,715 | -$22,987 | $25,841 | $18,600 |